FDA CBER

Interview with Bioheart CSO, Kristin Comella including on FDA

Kristin-Comella1

I invited the Chief Scientific Officer (CSO) of Bioheart, Kristin Comella, to do an interview after hearing some buzz that this could be a critical time for the company and that it might have been recently visited by the FDA. Note that Comella not just Bioheart CSO, but also the primary instructor for physician training in stem …

Interview with Bioheart CSO, Kristin Comella including on FDA Read More »

New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research

FDA3

It’s been a seemingly rather quiet year on the regulatory front in the US when it comes to direct-to-consumer stem cell interventions even as the number of dubious stem cell clinics continues to skyrocket. I requested an interview with the FDA to cover the key pressing issues in this arena. I want to thank the …

New Interview with FDA on Key Stem Cell Regulatory Issues & Its Own Research Read More »